Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 1
1949 2
1950 2
1951 1
1953 1
1954 5
1955 1
1956 1
1957 2
1958 4
1959 1
1961 2
1963 5
1964 2
1965 1
1966 1
1968 2
1969 3
1970 1
1971 1
1972 3
1973 2
1974 1
1975 6
1976 8
1977 1
1978 3
1979 4
1980 5
1981 6
1982 4
1983 2
1984 8
1985 6
1986 7
1987 7
1988 6
1989 8
1990 9
1991 15
1992 21
1993 19
1994 10
1995 20
1996 22
1997 15
1998 22
1999 14
2000 13
2001 22
2002 24
2003 25
2004 40
2005 33
2006 36
2007 41
2008 63
2009 63
2010 71
2011 92
2012 104
2013 107
2014 139
2015 129
2016 113
2017 116
2018 110
2019 142
2020 184
2021 246
2022 212
2023 169
2024 175
2025 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,463 results

Results by year

Filters applied: . Clear all
Page 1
Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial.
Villar J, Ferrando C, Martínez D, Ambrós A, Muñoz T, Soler JA, Aguilar G, Alba F, González-Higueras E, Conesa LA, Martín-Rodríguez C, Díaz-Domínguez FJ, Serna-Grande P, Rivas R, Ferreres J, Belda J, Capilla L, Tallet A, Añón JM, Fernández RL, González-Martín JM; dexamethasone in ARDS network. Villar J, et al. Among authors: martinez d. Lancet Respir Med. 2020 Mar;8(3):267-276. doi: 10.1016/S2213-2600(19)30417-5. Epub 2020 Feb 7. Lancet Respir Med. 2020. PMID: 32043986 Clinical Trial.
Targeting of intracellular oncoproteins with peptide-centric CARs.
Yarmarkovich M, Marshall QF, Warrington JM, Premaratne R, Farrel A, Groff D, Li W, di Marco M, Runbeck E, Truong H, Toor JS, Tripathi S, Nguyen S, Shen H, Noel T, Church NL, Weiner A, Kendsersky N, Martinez D, Weisberg R, Christie M, Eisenlohr L, Bosse KR, Dimitrov DS, Stevanovic S, Sgourakis NG, Kiefel BR, Maris JM. Yarmarkovich M, et al. Among authors: martinez d. Nature. 2023 Nov;623(7988):820-827. doi: 10.1038/s41586-023-06706-0. Epub 2023 Nov 8. Nature. 2023. PMID: 37938771 Free PMC article.
Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Dairy Farm Worker.
Uyeki TM, Milton S, Abdul Hamid C, Reinoso Webb C, Presley SM, Shetty V, Rollo SN, Martinez DL, Rai S, Gonzales ER, Kniss KL, Jang Y, Frederick JC, De La Cruz JA, Liddell J, Di H, Kirby MK, Barnes JR, Davis CT. Uyeki TM, et al. Among authors: martinez dl. N Engl J Med. 2024 Jun 6;390(21):2028-2029. doi: 10.1056/NEJMc2405371. Epub 2024 May 3. N Engl J Med. 2024. PMID: 38700506 No abstract available.
Retraction Note: Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs.
Yarmarkovich M, Marshall QF, Warrington JM, Premaratne R, Farrel A, Groff D, Li W, di Marco M, Runbeck E, Truong H, Toor JS, Tripathi S, Nguyen S, Shen H, Noel T, Church NL, Weiner A, Kendsersky N, Martinez D, Weisberg R, Christie M, Eisenlohr L, Bosse KR, Dimitrov DS, Stevanovic S, Sgourakis NG, Kiefel BR, Maris JM. Yarmarkovich M, et al. Among authors: martinez d. Nature. 2023 Nov;623(7988):872. doi: 10.1038/s41586-023-06731-z. Nature. 2023. PMID: 37938785 Free PMC article. No abstract available.
Frequency and spectrum of PIK3CA somatic mutations in breast cancer.
Martínez-Sáez O, Chic N, Pascual T, Adamo B, Vidal M, González-Farré B, Sanfeliu E, Schettini F, Conte B, Brasó-Maristany F, Rodríguez A, Martínez D, Galván P, Rodríguez AB, Martinez A, Muñoz M, Prat A. Martínez-Sáez O, et al. Among authors: martinez d. Breast Cancer Res. 2020 May 13;22(1):45. doi: 10.1186/s13058-020-01284-9. Breast Cancer Res. 2020. PMID: 32404150 Free PMC article.
Targeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancer.
Adam-Artigues A, Arenas EJ, Martínez-Sabadell A, Brasó-Maristany F, Cervera R, Tormo E, Hernando C, Martínez MT, Carbonell-Asins J, Simón S, Poveda J, Moragón S, Zazo S, Martínez D, Rovira A, Burgués O, Rojo F, Albanell J, Bermejo B, Lluch A, Prat A, Arribas J, Eroles P, Cejalvo JM. Adam-Artigues A, et al. Among authors: martinez d. Sci Adv. 2022 May 20;8(20):eabk2746. doi: 10.1126/sciadv.abk2746. Epub 2022 May 20. Sci Adv. 2022. PMID: 35594351 Free PMC article.
1º Posicionamento Brasileiro sobre o Impacto dos Distúrbios de Sono nas Doenças Cardiovasculares da Sociedade Brasileira de Cardiologia.
Drager LF, Lorenzi-Filho G, Cintra FD, Pedrosa RP, Bittencourt LRA, Poyares D, Carvalho CG, Moura SMGPT, Santos-Silva R, Bruin PFC, Geovanini GR, Albuquerque FN, Oliveira WAA, Moreira GA, Ueno LM, Nerbass FB, Rondon MUPB, Barbosa ERF, Bertolami A, Paola AAV, Marques BBS, Rizzi CF, Negrão CE, Uchôa CHG, Maki-Nunes C, Martinez D, Fernández EA, Maroja FU, Almeida FR, Trombetta IC, Storti LJ, Bortolotto LA, Mello MT, Borges MA, Andersen ML, Portilho NP, Macedo P, Alves R, Tufik S, Fagondes SC, Risso TT. Drager LF, et al. Among authors: martinez d. Arq Bras Cardiol. 2018 Aug;111(2):290-340. doi: 10.5935/abc.20180154. Arq Bras Cardiol. 2018. PMID: 30335871 Free article. Portuguese. No abstract available.
Open Lung Approach for the Acute Respiratory Distress Syndrome: A Pilot, Randomized Controlled Trial.
Kacmarek RM, Villar J, Sulemanji D, Montiel R, Ferrando C, Blanco J, Koh Y, Soler JA, Martínez D, Hernández M, Tucci M, Borges JB, Lubillo S, Santos A, Araujo JB, Amato MB, Suárez-Sipmann F; Open Lung Approach Network. Kacmarek RM, et al. Among authors: martinez d. Crit Care Med. 2016 Jan;44(1):32-42. doi: 10.1097/CCM.0000000000001383. Crit Care Med. 2016. PMID: 26672923 Clinical Trial.
Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer.
Prat A, Guarneri V, Pascual T, Brasó-Maristany F, Sanfeliu E, Paré L, Schettini F, Martínez D, Jares P, Griguolo G, Dieci MV, Cortés J, Llombart-Cussac A, Conte B, Marín-Aguilera M, Chic N, Puig-Butillé JA, Martínez A, Galván P, Tsai YH, González-Farré B, Mira A, Vivancos A, Villagrasa P, Parker JS, Conte P, Perou CM. Prat A, et al. Among authors: martinez d. EBioMedicine. 2022 Jan;75:103801. doi: 10.1016/j.ebiom.2021.103801. Epub 2022 Jan 3. EBioMedicine. 2022. PMID: 34990895 Free PMC article.
2,463 results